{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:54:50Z","timestamp":1777679690409,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105135","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:41:12Z","timestamp":1773369672000},"source":"Crossref","is-referenced-by-count":1,"title":["Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Negative Statin-Induced Necrotizing Myopathy: A Challenging Case"],"prefix":"10.7759","author":[{"given":"Alexander S","family":"Kaiteris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ayob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27504","article-title":"Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota","volume":"65","author":"Shelly S","year":"2022","unstructured":"Shelly S, Mielke MM, Paul P, et al.. Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota. Muscle Nerve. 2022, 65:541-6. 10.1002\/mus.27504","journal-title":"Muscle Nerve"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.114108","article-title":"Statin-induced necrotizing autoimmune myopathy: a systematic review","volume":"60","author":"Somagutta MK","year":"2022","unstructured":"Somagutta MK, Shama N, Pormento MK, et al.. Statin-induced necrotizing autoimmune myopathy: a systematic review. Reumatologia. 2022, 60:63-9. 10.5114\/reum.2022.114108","journal-title":"Reumatologia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.04.002","article-title":"Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines","volume":"31","author":"Matyori A","year":"2023","unstructured":"Matyori A, Brown CP, Ali A, Sherbeny F. Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines. Saudi Pharm J. 2023, 31:795-800. 10.1016\/j.jsps.2023.04.002","journal-title":"Saudi Pharm J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2022.18.2.89","article-title":"Statin-related muscle toxicity: an evidence-based review","volume":"18","author":"Jeeyavudeen MS","year":"2022","unstructured":"Jeeyavudeen MS, Pappachan JM, Arunagirinathan G. Statin-related muscle toxicity: an evidence-based review. touchREV Endocrinol. 2022, 18:89-95. 10.17925\/EE.2022.18.2.89","journal-title":"touchREV Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel P","year":"2018","unstructured":"Mohassel P, Mammen AL. Anti-HMGCR myopathy. J Neuromuscul Dis. 2018, 5:11-20. 10.3233\/JND-170282","journal-title":"J Neuromuscul Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-025-00481-2","article-title":"Trends in reports of statin-associated immune-mediated necrotizing myopathy using the Japanese Adverse Drug Event Report database","volume":"12","author":"Takami A","year":"2025","unstructured":"Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A. Trends in reports of statin-associated immune-mediated necrotizing myopathy using the Japanese Adverse Drug Event Report database. Drugs Real World Outcomes. 2025, 12:145-52. 10.1007\/s40801-025-00481-2","journal-title":"Drugs Real World Outcomes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.12.019","article-title":"Statin-induced necrotizing autoimmune myopathy","volume":"2","author":"Gawey B","year":"2020","unstructured":"Gawey B, Tannu M, Rim J, Sperling L, Henry TL. Statin-induced necrotizing autoimmune myopathy. JACC Case Rep. 2020, 2:440-3. 10.1016\/j.jaccas.2019.12.019","journal-title":"JACC Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03278-9","article-title":"Statin-induced autoimmune myositis: a proposal of an \"experience-based\" diagnostic algorithm from the analysis of 69 patients","volume":"18","author":"Gagliardo CM","year":"2023","unstructured":"Gagliardo CM, Noto D, Giammanco A, et al.. Statin-induced autoimmune myositis: a proposal of an \"experience-based\" diagnostic algorithm from the analysis of 69 patients. Intern Emerg Med. 2023, 18:1095-107. 10.1007\/s11739-023-03278-9","journal-title":"Intern Emerg Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00174-1","article-title":"Therapeutic management of immune-mediated necrotizing myositis","volume":"7","author":"Weeding E","year":"2021","unstructured":"Weeding E, Tiniakou E. Therapeutic management of immune-mediated necrotizing myositis. Curr Treatm Opt Rheumatol. 2021, 7:150-60. 10.1007\/s40674-021-00174-1","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329197","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie MM","year":"2012","unstructured":"Dimachkie MM, Barohn RJ. Inclusion body myositis. Semin Neurol. 2012, 32:237-45. 10.1055\/s-0032-1329197","journal-title":"Semin Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2020","article-title":"The concomitant use of atorvastatin and amlodipine leading to rhabdomyolysis","volume":"10","author":"Khan S","year":"2018","unstructured":"Khan S, Khan I, Novak M, Regmi A, Difilippo W. The concomitant use of atorvastatin and amlodipine leading to rhabdomyolysis. Cureus. 2018, 10:e2020. 10.7759\/cureus.2020","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387824-anti-3-hydroxy-3-methylglutaryl-coenzyme-a-hmg-coa-reductase-negative-statin-induced-necrotizing-myopathy-a-challenging-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:41:13Z","timestamp":1773369673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387824-anti-3-hydroxy-3-methylglutaryl-coenzyme-a-hmg-coa-reductase-negative-statin-induced-necrotizing-myopathy-a-challenging-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.105135","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}